Douglas Kramer
Douglas Kramer publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Hematology, on topics such as Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies and HER2/EGFR in Cancer Research.
- World rank
- #5,978,116 of 7,710,434 ranked researchers
- Rank in United States
- #1,458,671 of 1,627,098
- Works
- 25
- Citations
- 91
- Citations per work
- 3.6
What does Douglas Kramer research?
Douglas Kramer's work is mostly in Medicine (88%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2287.6%
- Medicine2287.6%
- Everything else28.3%
- Life Sciences14.1%
- 1Oncology57% of their works
- 2Pulmonary and Respiratory Medicine11% of their works
- 3Hematology10% of their works
- 4Radiology, Nuclear Medicine and Imaging7% of their works
- 5Molecular Biology4% of their works
- 6Hepatology3% of their works
Research topics
Which keywords describe Douglas Kramer's research?
The keywords of their largest research topics: Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Chemotherapy, Cetuximab, KRAS Mutations, Targeted Therapy, Breast Cancer and HER2.
- Pharmacogenetics
- EGFR Mutations
- AML
- Radiopharmaceuticals
- Multidrug Resistance
- HER2
- Targeted Therapy
- Cetuximab
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Chemotherapy
- KRAS Mutations
- Breast Cancer
- ATP-dependent Transporters
- PET Imaging
- ALK Inhibitors
- Acute Myeloid Leukemia
- Cytochrome P450
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Chemotherapy-Induced Peripheral Neuropathy201 topic
- Taxanes201 topic
- Chemotherapy132 topics
- Cetuximab71 topic
- KRAS Mutations71 topic
- Targeted Therapy72 topics
- Breast Cancer61 topic
- HER261 topic
- ATP-dependent Transporters51 topic
- Multidrug Resistance51 topic
- PET Imaging41 topic
- Radiopharmaceuticals41 topic
- ALK Inhibitors31 topic
- AML31 topic
- Acute Myeloid Leukemia31 topic
- EGFR Mutations31 topic
- Cytochrome P45021 topic
- Pharmacogenetics21 topic
Where does Douglas Kramer work?
Douglas Kramer's main affiliation in the publication record is Athenex (United States), United States.
How many publications and citations does Douglas Kramer have?
OpenAlex counts 25 works and 91 citations for Douglas Kramer, an h-index of 6, ranking #5,978,116 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Douglas Kramer. Posts are plain text and can be reported.